stockrow
Friday 6 November 2026
Export HDSN’s income statement to Excel — free account
Hudson Technologies, Inc.
HDSN Basic Materials Specialty Chemicals
Hudson Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $246.6 million, up 4.00% from fiscal 2024.
- Revenue
- −19.7%
- EPS
- −82.1%
- Free cash flow
- +43.4%
Quarter to September 2026, against a year earlier
4.19
0.10
+2.44%
Follow HDSN
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 27.62 | 18.50 | 18.51 |
+8 more quarters Free account |
P/S ratio |
0.89 | 0.94 | 0.99 | 1.21 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
21.36 | 35.26 | (19.43) | (9.17) | |
P/B ratio |
0.88 | 0.99 | 1.05 | 1.23 | |
Price to Tangible BV |
1.26 | 1.43 | 1.54 | 1.79 | |
EV/Sales |
0.87 | 0.96 | 1.03 | 1.17 | |
EV/EBITDA |
11.64 | 13.54 | 11.13 | 11.67 | |
EV/Operating CF |
(7.46) | (8.29) | (8.62) | (91.46) | |
EV/FCF |
(6.69) | (7.12) | (7.45) | (35.11) | |
Quick Ratio |
1.10 | 1.12 | 0.97 | 0.97 | |
Current Ratio |
3.40 | 3.23 | 3.38 | 3.26 | |
Net Debt/EBITDA |
0.00 | (2.79) | (5.94) | 4.05 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.74 | 0.80 | 0.82 | 0.79 | |
Operating CF/Net income |
4.98 | 1.38 | (38.80) | 3.77 | |
Capex/Depreciation |
0.00 | (0.32) | (0.60) | (0.75) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
18.19% | 15.87% | 15.84% | 31.35% | |
Intangible Assets out of Total Assets |
0.23 | 0.23 | 0.25 | 0.24 | |
Share Based Compensation of Revenue |
0.39% | 0.86% | 0.28% | 1.06% | |
Graham Net Nets |
0.66 | 0.58 | 0.53 | 0.45 | |
Graham Number |
0.00 | 5.20 | 6.34 | 6.82 | |
Earnings Yield |
(0.43%) | 3.62% | 5.40% | 5.40% | |
Free Cash Flow Yield |
(14.58%) | (14.30%) | (14.01%) | (2.76%) | |
Revenue per Share |
1.41 | 1.86 | 1.42 | 1.02 | |
Operating CF per Share |
0.24 | 0.16 | (0.30) | (0.75) | |
Capex per Share |
(0.01) | (0.01) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.23 | 0.15 | (0.33) | (0.77) | |
Cash per Share |
0.84 | 0.61 | 0.46 | 0.91 | |
Shareholders Equity per Share |
5.83 | 5.78 | 5.62 | 5.58 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.83 | 5.78 | 5.62 | 5.58 | |
Free Cash Flow |
9.67 | 6.27 | (13.88) | (33.65) | |
Working Capital |
153.65 | 150.65 | 142.96 | 146.24 | |
Capital Expenditures |
(0.47) | (0.58) | (1.07) | (1.11) | |
Net Current Asset Value |
143.38 | 139.35 | 131.84 | 135.58 | |
EV/EBIT |
233.79 | 21.16 | 15.32 | 15.58 | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.03 | |
Price to Operating Income |
239.51 | 20.78 | 14.68 | 16.09 | |
| Other line items | |||||
Average Receivables |
32.51 | 44.60 | 36.17 | 21.46 | |
Average Payables |
— | 17.79 | 14.43 | 14.90 | |
Average Inventory |
114.46 | 102.90 | 104.52 | 116.09 | |
Average Assets |
329.44 | 319.96 | 308.40 | 310.65 | |
Average Common Equity |
255.71 | 249.02 | 242.25 | 244.62 |
Columns are period end dates · fundamentals updated 5 Nov 2026